Triple-negative breast cancer: multipronged approach, single-arm pilot phase II study

Anthracyclines (A) and taxanes (T) are standard first-line chemotherapy agents for patients with advanced breast cancer. Platinum analogues have also shown activity in the triple-negative breast cancer (TNBC) histology, but clinical data are limited. Here we report the long-term follow-up of a phase...

Descripción completa

Detalles Bibliográficos
Autores principales: Recchia, Francesco, Candeloro, Giampiero, Desideri, Giovambattista, Necozione, Stefano, Recchia, Cornelia O C, Cirulli, Vincenzo, Rea, Silvio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544434/
https://www.ncbi.nlm.nih.gov/pubmed/23342258
http://dx.doi.org/10.1002/cam4.3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544434/
https://www.ncbi.nlm.nih.gov/pubmed/23342258
http://dx.doi.org/10.1002/cam4.3

Ejemplares similares